GlassScriptPhysician profile
Mario E Mariani
NPI 1487680344
$8,800.42
in general payments reported to CMS, 2019-2025
50 companies · $2,375 in 2025
The $2,375 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $539 · 2021: $699 · 2022: $1,172 · 2023: $1,642 · 2024: $1,928 · 2025: $2,375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,944.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,716.88 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $946.19 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $763.20 | 2022-2025 | |
| Amgen INC. | $545.33 | 2019-2025 | Evenity, Repatha, Otezla |
| Lilly USA, LLC | $516.32 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $499.14 | 2019-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $391.65 | 2024-2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $272.71 | 2021-2025 | Jardiance, Jascayd, Ofev |
| Bayer Healthcare Pharmaceuticals INC. | $242.66 | 2022-2025 | |
| Abbott Laboratories | $217.71 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Janssen Pharmaceuticals, INC | $198.56 | 2020-2022 | |
| Amarin Pharma, INC. | $194.91 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $190.77 | 2020-2025 | |
| Sanofi-Aventis U.S. LLC | $189.80 | 2019-2023 | |
| Glaxosmithkline, LLC. | $187.02 | 2022-2025 | Shingrix, Arexvy, Trelegy Ellipta |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $170.31 | 2023-2025 | Veozah |
| Otsuka America Pharmaceutical, INC. | $139.71 | 2023-2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $132.95 | 2020-2023 | Seglentis |
| Xeris Pharmaceuticals, INC. | $102.44 | 2023-2025 | Gvoke Hypopen |
| Exact Sciences Corporation | $101.91 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Inspire Medical Systems, INC. | $94.87 | 2023-2025 | Inspire |
| Dexcom, INC. | $94.38 | 2022-2025 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.79 | 2021-2025 | Xifaxan, Trulance |
| Biogen, INC. | $80.07 | 2024-2025 | Skyclarys |
| Genzyme Corporation | $70.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.68 | 2020-2024 | Trintellix |
| E.R. Squibb & Sons, L.L.C. | $65.78 | 2020-2024 | Eliquis |
| Lundbeck LLC | $54.15 | 2024-2025 | Rexulti |
| Arbor Pharmaceuticals, INC. | $35.90 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $30.86 | 2023 | Quviviq |
| Axsome Therapeutics, INC. | $28.12 | 2025 | Auvelity |
| Allergan, INC. | $27.51 | 2019 | |
| Insulet Corporation | $26.89 | 2025 | Omnipod |
| Tonix Medicines, INC. | $26.45 | 2025 | Tonmya |
| Supernus Pharmaceuticals, INC. | $24.48 | 2023 | Qelbree |
| Almatica Pharma LLC | $21.85 | 2025 | Loreev Xr |
| Vertex Pharmaceuticals Incorporated | $20.44 | 2025 | |
| Kerecis Limited | $20.33 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Verona Pharma, INC. | $20.25 | 2025 | Ohtuvayre |
| Seqirus USA INC | $19.27 | 2021 | |
| Nevro Corp. | $18.95 | 2023 | Senza |
| Eisai INC. | $18.01 | 2021 | |
| Medtronic, INC. | $18.00 | 2025 | Inceptiv |
| Eyevance Pharmaceuticals LLC | $17.75 | 2021 | |
| Hikma Pharmaceuticals USA | $17.75 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.38 | 2022 | |
| Merck Sharp & Dohme LLC | $16.98 | 2023 | Belsomra |
| Amneal Pharmaceuticals LLC | $14.87 | 2025 | Unithroid |
| Phathom Pharmaceuticals, INC. | $13.94 | 2024 | Voquezna |
| Valeritas, INC. | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Mariani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.